Thank you, Peter, and good morning, everybody. As a reminder, Kelly 2023 results included the European staffing business that was sold on January 2, 2024, and our 2024 results include Motion Recruitment Partners since the May 31 acquisition date. To provide greater visibility into trends in our operating results, I will discuss year-over-year changes on a reported and also on an organic basis. References to organic information excludes the results of our European staffing business in 2023 and the impact of the acquisition of MRP in 2024. Revenue for the third quarter of 2024 totaled $1.04 billion compared to $1.12 billion in 2023, down 7.1%, resulting primarily from the sale of our European staffing business, partially offset by the acquisition of MRP. On an organic basis, year-over-year revenue was essentially flat and down 0.2%. This is slightly lower than what we have built into our second half outlook. Reviewing results by segment, starting with Education. Q3 is low season for Education because of summer in much of our K-12 practices, but we continued to deliver sustained double-digit revenue growth, up 11% year-over-year in the quarter. This growth continues to reflect net new customer wins and an improving fill rate on existing business. In the SETT segment, revenue was up 37% on a reported basis, resulting from the acquisition of MRP, which is included in our results for a full quarter in Q3. Revenue was down 5% on an organic basis. Organic revenue trends were weaker over some months but improved in September as we exited the quarter. For the total quarter, organic year-over-year trends reflect lower staffing market demand with revenue down 5% in our staffing specialties as well as in our outcome-based solutions, driven primarily by lower demand in certain industry verticals like telecom. We continue to see the outcome-based statement of work business as a growing portion of the market where we are focused and continue to innovate. Permanent placement fees declined 31% organically but more than doubled when including the results of MRP, which has a strong direct hire business. In our OCG segment, revenue improved 6%. The increase in revenues continues to be driven by our PPO specialty. Year-over-year declines in RPO are due to slower hiring in certain market sectors, and MSP revenues declined in line with customers' contingent labor demand. Adding lower-margin PPO revenue put some pressure on gross margin for the OCG segment as a whole again this quarter, but revenue in both MSP and RPO products were stable sequentially. And our higher-margin MSP product is well positioned to benefit from positive momentum in the sales pipeline moving into 2025. Revenue in our Professional & Industrial segment declined 2% year-over-year in the quarter. P&I sequential revenue stabilization in Q2 turned to sequential revenue growth of 4% in Q3. Revenue from our staffing product declined 3% year-over-year. And revenue in our outcome-based specialties was flat year-over-year. Consistent with SETT, we are seeing strong demand for innovative solutions to meet clients' talent needs across a variety of skill sets in P&I. As demand for the segment's contact center specialty has declined, P&I has successfully diversified its portfolio of outcome-based solutions. Overall, gross profit was down 3% as reported or 6.4% on an organic basis. Our reported gross profit rate was 21.4% compared to 20.4% in the third quarter of 2023. Our GP rate reflects a 130 basis point improvement from the sale of our European staffing operations and an additional 110 basis points from the inclusion of MRP for a full quarter. Excluding those impacts on an organic basis, the GP rate declined 140 basis points in Q3, consistent with the trends we have seen in Q2. Drivers of the trend include 110 -- 120 basis point from business mix and 30 basis points from lower perm fees, partially offset by 10 basis points of favorable employee-related costs. The business mix impact continued to reflect growth in lower GP rate specialties. SG&A expenses were down 4.1% year-over-year on a reported basis. Expenses for the third quarter of 2024 includes $6.1 million of costs related to integrating MRP; as well as further aligning processes and technology across the company; and also $1.8 million of transition expenses related to the sale of our European staffing operations; and finally, $1.4 million of transaction costs associated with the acquisition of MRP. SG&A expenses in 2023 includes $15.4 million of restructuring charges. So on an adjusted organic basis, SG&A expense declined 4%. So like-for-like expenses were lower in Q3 2024, reflecting organic top line trends and management's effort to align resource levels with volume as well as the impact on variable performance-related incentive compensation expenses. On a consolidated basis, our reported earnings from operations in the third quarter were $2.6 million compared to $0.1 million in Q3 2023. On an adjusted basis, Q3 2024 earnings from operations were $11.7 million compared to $15.5 million a year ago. The acquisition of MRP added $2 million of earnings from operations in the third quarter of 2024. Adjusted EBITDA margin improved 20 basis points to 2.5%, reflecting 30 basis points of improvement from the sale of our European staffing operations, 30 basis points from the inclusion of MRP, partially offset by a 40 basis point decline in our organic EBITDA margin. Following the borrowings related to the acquisition of MRP, interest expense, net of interest income, which is reported as a component of other income and expense net, has increased $4.3 million year-over-year in Q3. Income tax benefit for the third quarter was $2.6 million compared to a benefit of $4.9 million in 2023. And finally, reported earnings per share for the third quarter was $0.02 per share compared to $0.18 in 2023. Earnings per share in 2024 include integration costs net of tax of $0.12 and $0.06 of transaction costs net of tax. Earnings per share in 2023 included $0.32 of restructuring charges net of tax. So on an adjusted basis, Q3 2024 EPS was $0.21 compared to $0.50 per share in Q3 of 2023. The change in earnings per share include $0.09 of additional interest expensive -- expenses following the acquisition of MRP in May 2024 and the impact of a onetime deferred income tax valuation allowance release of $0.14 in 2023. Now reflecting on the balance sheet. At the end of the quarter, total available liquidity was at $159 million, comprised of $33 million in cash and $126 million of available capacity on our credit facility. Borrowings totaled $228 million. Our debt-to-capital ratio is 15.6% at quarter end as we leveraged our strong balance sheet to acquire MRP. And our credit facilities give us the financial flexibility for additional organic and inorganic investment and to navigate an ongoing uncertain market environment. At quarter end, accounts receivable totaled $1.2 billion, including the receivables of MRP. Global DSO was 64 days, up 1 day from the third quarter of 2023. With continued growth in our Education business, we experienced a more pronounced seasonal DSO pattern in which DSO is the lowest in Q2 and the highest in Q3, making sequential comparisons less meaningful than in the past. Year-to-date, we have generated $3 million of free cash flow compared to $21 million in the comparable period -- prior year period. Now looking ahead to operating results for the fourth quarter. We believe that staffing market conditions will remain relatively consistent with what we have experienced in Q3 and expect continued stabilization in revenue in our P&I, SETT and OCG segments. With the start of the school year behind us, our Education segment revenue will ramp sequentially from Q3 to Q4 and will continue to produce double-digit year-over-year revenue growth. And finally, the acquisition of MRP will deliver further improvement in both our growth and also value metrics. For the first quarter, on an organic basis, we expect revenue to be up 1.5% to 2.5% with no significant FX impact, resulting in a midpoint revenue expectation of $1.045 billion on an organic basis. In addition, we expect MRP to add an additional $120 million of revenue in the quarter. We expect our organic GP rate to be about 19.3% for Q4, reflecting the continuation of a change in our business mix, primarily because the Education segment is expected to continue to deliver significant revenue growth. MRP with its higher-margin specialty profile is expected to add an additional 110 basis points to our current gross margin rate in Q4. So all in, our GP rate in Q4 is expected to be about 20.4%. Reflecting on SG&A, we expect to sustain the efficiency improvements that we gained from our transformation-related actions over the past year and are actively managing resources in line with revenue trends in each segment. We expect that adjusted SG&A, excluding depreciation and amortization, will be 4.5% to 5.5% lower than a year ago on an organic basis, and MRP will add about $30 million of expenses in the quarter. All in, we expect approximately $14 million of depreciation and amortization in the fourth quarter. We expect an adjusted EBITDA margin of 3.4% to 3.5%, up about 90 basis points year-over-year, including a 30 basis point improvement from the acquisition of MRP. And finally, we expect our effective tax rate to be in the low teens. And now back to you, Peter.